069620.KO · Daewoong pharmaceutical Co.,Ltd

-

Please sign in to comment on 069620.KO

1 Comment

Admin

4 years ago

Daewoong pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 17.1% above its 200 day moving average.

From a valuation standpoint, the stock is 84.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.

Daewoong pharmaceutical Co.,Ltd's total revenue sank by 7.1% to $267B since the same quarter in the previous year.

Its net income has increased by 458.7% to $18B since the same quarter in the previous year.

Finally, its free cash flow grew by 130.8% to $13B since the same quarter in the previous year.

Based on the above factors, Daewoong pharmaceutical Co.,Ltd gets an overall score of 4/5.

Exchange	KO
CurrencyCode	KRW
ISIN	KR7069620003
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare

Beta	0.68
Market Cap	1T
PE Ratio	None
Target Price	204375
Dividend Yield	0.5%

ABOUT

Daewoong pharmaceutical Co.,Ltd

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.

069620.KO · Daewoong pharmaceutical Co.,Ltd

-

Daewoong pharmaceutical Co.,Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Daewoong pharmaceutical Co.,Ltd using a moving average strategy